INMB logo

INMBINmune Bio Inc

$1.32
$0.04
(3.13%)
Pre-Market
Updated: 04:00 AM EDT·Prev Close $1.28
EarningsAug 6
Mkt Cap$34.03M
Vol72.00

About

INmune Bio, Inc. is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprogram the immune system to fight cancer and Alzheimer’s disease. The company was founded by Mark Lowdell on September 25, 2015 and is headquartered in Boca Raton, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
21

Frequently Asked Questions

What is Market Cap of INmune Bio Inc?
What is the 52-week high for INmune Bio Inc?
What is the 52-week low for INmune Bio Inc?
What is INmune Bio Inc stock price today?
What was INmune Bio Inc stock price yesterday?
What is the PE ratio of INmune Bio Inc?
What is the Price-to-Book ratio of INmune Bio Inc?
What is the 50-day moving average of INmune Bio Inc?
How many employees does INmune Bio Inc have?

Advertisement|Remove ads.